Michael Gleeson, SVP, Corporate Accounts at GenMark Diagnostics, Inc. (GNMK), sold 90,336 shares at $7.96 ($715K) on 2019-02-27, disclosed to the SEC on 2019-03-01.
Seasonal sale ($715k) by SVP, Corporate Accounts — this insider has traded GNMK in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.96 | 26,704 | $213K | 29.7% |
| 2 | $7.96 | 26,704 | $213K | 29.7% |
| 3 | $7.84 | 18,464 | $145K | 20.3% |
| 4 | $7.84 | 18,464 | $145K | 20.3% |
| Total | $7.91 avg | 90,336 | $715K | 100% |
| Filing → |
| GNMK | SELL | 2021-02-22 | $51K | — | Filing → |
| GNMK | SELL | 2021-01-25 | $939K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $43K | — | Filing → |